Cortisone Shots Market Therapeutics Research Report - Global Forecast Till 2023

Page 1

Cortisone Shots Market Synopsis, Growth Analysis, Clinical Review and Business Outlook 2018 – 2023

Cortisone shots are used of the treatment of a spectrum of diseases. Rising prevalence of chronic diseases such as rheumatoid arthritis, osteoarthritis, tendinitis and other diseases, extensive demand for the treatment of severe sport injuries and increasing number of sport medicine centers stimulate the growth of the market. Presence of key players also boost the growth of the market. The growth of the market is restricted due to the side effects of cortisone shots such as joint infection, and nerve damage. Avail FREE Sample Here: https://www.marketresearchfuture.com/sample_request/4847 The global cortisone shots market is expected to grow at a CAGR of 5.2% during the forecast period. In dermatology, these shot are administered for skin conditions such as shingles, whereas in orthopedic they are used to treat joint pain and in the treatment of diseases such as osteoarthritis, and tendinitis. Medical practitioners also administer cortisone shots in the gluteus muscle to treat an allergic reaction. Market Top Players Some of the key players in the global market are Merck & Co. Inc. (U.S.) Pfizer (U.S.) Bristol-Myers Squibb Company (U.S.) Novartis AG (Germany) GlaxoSmithKline (U.S.) Pharmascience Inc. (U.S.) Farmabios SPA (Italy) AdvaCare Pharma (U.S.) And others. Market Segments The global cortisone shots market is segmented on the basis of type, indication, and end user.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.